These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 38213536)

  • 1. Current implications and challenges of artificial intelligence technologies in therapeutic intervention of colorectal cancer.
    Das K; Paltani M; Tripathi PK; Kumar R; Verma S; Kumar S; Jain CK
    Explor Target Antitumor Ther; 2023; 4(6):1286-1300. PubMed ID: 38213536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for colon cancer: A test for occult blood.
    Khakimov N; Khasanova G; Ershova K; Gibadullina L; Vetkina T; Lobisheva G; Chumakova A
    Int J Risk Saf Med; 2015; 27 Suppl 1():S110-1. PubMed ID: 26639687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial Intelligence in Colorectal Cancer Screening, Diagnosis and Treatment. A New Era.
    Mitsala A; Tsalikidis C; Pitiakoudis M; Simopoulos C; Tsaroucha AK
    Curr Oncol; 2021 Apr; 28(3):1581-1607. PubMed ID: 33922402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.
    Tinmouth J; Lansdorp-Vogelaar I; Allison JE
    Gut; 2015 Aug; 64(8):1327-37. PubMed ID: 26041750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantifying the impact of adherence to screening strategies on colorectal cancer incidence and mortality.
    D'Andrea E; Ahnen DJ; Sussman DA; Najafzadeh M
    Cancer Med; 2020 Jan; 9(2):824-836. PubMed ID: 31777197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing the accuracy of colorectal cancer screening.
    Pecere S; Ciuffini C; Chiappetta MF; Petruzziello L; Papparella LG; Spada C; Gasbarrini A; Barbaro F
    Expert Rev Anticancer Ther; 2023 Jun; 23(6):583-591. PubMed ID: 37099725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sensitivity, specificity, predictive values, and likelihood ratios of fecal occult blood test for the detection of colorectal cancer in hospital settings.
    Elsafi SH; Alqahtani NI; Zakary NY; Al Zahrani EM
    Clin Exp Gastroenterol; 2015; 8():279-84. PubMed ID: 26392783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Lin JS; Perdue LA; Henrikson NB; Bean SI; Blasi PR
    JAMA; 2021 May; 325(19):1978-1998. PubMed ID: 34003220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer screening: tests, strategies, and perspectives.
    Stracci F; Zorzi M; Grazzini G
    Front Public Health; 2014; 2():210. PubMed ID: 25386553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reimagining Colorectal Cancer Screening: Innovations and Challenges with Dr. Aasma Shaukat.
    Cortiana V; Joshi M; Chorya H; Vallabhaneni H; Kannan S; Coloma HS; Park CH; Leyfman Y
    Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of artificial intelligence in diagnosis and treatment of colorectal cancer: A novel Prospect.
    Yin Z; Yao C; Zhang L; Qi S
    Front Med (Lausanne); 2023; 10():1128084. PubMed ID: 36968824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artificial intelligence in gastrointestinal endoscopy.
    Pannala R; Krishnan K; Melson J; Parsi MA; Schulman AR; Sullivan S; Trikudanathan G; Trindade AJ; Watson RR; Maple JT; Lichtenstein DR
    VideoGIE; 2020 Dec; 5(12):598-613. PubMed ID: 33319126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Lin JS; Piper MA; Perdue LA; Rutter CM; Webber EM; O'Connor E; Smith N; Whitlock EP
    JAMA; 2016 Jun; 315(23):2576-94. PubMed ID: 27305422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Men with negative results of guaiac-based fecal occult blood test have higher prevalences of colorectal neoplasms than women with positive results.
    Brenner H; Hoffmeister M; Birkner B; Stock C
    Int J Cancer; 2014 Jun; 134(12):2927-34. PubMed ID: 24374771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.
    Benito L; Travier N; Binefa G; Vidal C; Espinosa J; Milà N; Garcia M
    Cancer Prev Res (Phila); 2019 May; 12(5):327-334. PubMed ID: 30890542
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.